Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
1996-11-4
|
pubmed:abstractText |
Angiogenesis is a key process in tumor growth and metastasis and is a major independent prognostic factor in breast cancer. A range of cytokines stimulate the tumor neovasculature, and tumor-associated macrophages have been shown recently to produce several important angiogenic factors. We have quantified macrophage infiltration using Chalkley count morphometry in a series of invasive breast carcinomas to investigate the relationship between tumor-associated macrophage infiltration and tumor angiogenesis, and prognosis. There was a significant positive correlation between high vascular grade and increased macrophage index (P = 0.03), and a strong relationship was observed between increased macrophage counts and reduced relapse-free survival (P = 0.006) and reduced overall survival (P = 0.004) as an independent prognostic variable. These data indicate a role for macrophages in angiogenesis and prognosis in breast cancer and that this cell type may represent an important target for immunoinhibitory therapy in breast cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4625-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8840975-Breast Neoplasms,
pubmed-meshheading:8840975-Cell Count,
pubmed-meshheading:8840975-Cell Movement,
pubmed-meshheading:8840975-Disease-Free Survival,
pubmed-meshheading:8840975-Female,
pubmed-meshheading:8840975-Humans,
pubmed-meshheading:8840975-Macrophages,
pubmed-meshheading:8840975-Multivariate Analysis,
pubmed-meshheading:8840975-Neovascularization, Pathologic
|
pubmed:year |
1996
|
pubmed:articleTitle |
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
|
pubmed:affiliation |
Imperial Cancer Research Fund Molecular Oncology Laboratory, University of Oxford Institute of Molecular Medicine, England.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|